September 17, 2024 11:31 AM EDT
News Briefing

Capri­cor ex­pands DMD pact with Nip­pon Shinyaku; Ab­b­Vie’s new eye deal

ENDPOINTS

Plus, news about Vig­il Neu­ro­science, AC Im­mune and Athi­ra Phar­ma:

Capri­cor Ther­a­peu­tics, Nip­pon Shinyaku ex­pand com­mer­cial pact in­to Eu­rope: The

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

A service from the Financial Times